Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Leases (2018 - 2025)

Historic Leases for Cytosorbents (CTSO) over the last 8 years, with Q3 2025 value amounting to $11.1 million.

  • Cytosorbents' Leases fell 494.84% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year decrease of 494.84%. This contributed to the annual value of $11.5 million for FY2024, which is 454.35% down from last year.
  • Cytosorbents' Leases amounted to $11.1 million in Q3 2025, which was down 494.84% from $11.2 million recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Leases ranged from a high of $13.7 million in Q3 2021 and a low of $923960.0 during Q1 2021
  • Moreover, its 5-year median value for Leases was $12.2 million (2023), whereas its average is $11.7 million.
  • Over the last 5 years, Cytosorbents' Leases had its largest YoY gain of 132828.64% in 2022, and its largest YoY loss of 627.97% in 2022.
  • Over the past 5 years, Cytosorbents' Leases (Quarter) stood at $13.4 million in 2021, then dropped by 6.11% to $12.6 million in 2022, then fell by 4.32% to $12.1 million in 2023, then fell by 4.54% to $11.5 million in 2024, then decreased by 3.79% to $11.1 million in 2025.
  • Its Leases stands at $11.1 million for Q3 2025, versus $11.2 million for Q2 2025 and $11.4 million for Q1 2025.